SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories gets nod for share buyback

09 Jan 2018 Evaluate

Unichem Laboratories has received its board’s approval for buyback proposal. The company is planning to buy 2.06 crore equity shares (being less than 25 per cent of the total paid-up equity capital of the company) at a price of Rs 430 a share for an aggregate amount not exceeding Rs 885.80 crore. The buyback would be on proportionate basis through the tender offer route and the company will announce the record date later.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. 

Unichem Lab Share Price

385.10 -6.85 (-1.75%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×